Insider · CIK 0001839156
Corinne Epperly
Files at INAB (IN8BIO, INC.). First filing -, latest -.
In brief
Corinne Epperly files SEC Form 4 as director at INAB (IN8BIO, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Corinne Epperly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 9, 2026 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +22,000 | $0.00 | $0 | 22,000 | May 12, 2026 |
| May 8, 2025 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +63,150 | $0.00 | $0 | 63,150 | May 12, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | DDisposition to issuer Series B Warrants (right to buy)derivative | -81,967 | - | - | 0 | May 7, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | AGrant or award Series B Warrants (right to buy)derivative | +81,967 | - | - | 81,967 | May 7, 2025 |
| Dec 19, 2024 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +37,655 | $0.00 | $0 | 37,655 | Dec 23, 2024 |
| Jun 12, 2024 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +33,650 | $0.00 | $0 | 33,650 | Jun 14, 2024 |
| Feb 7, 2024 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Feb 8, 2024 |
| Dec 13, 2023 | INAB IN8BIO, INC. | AGrant or award Common Stock | +81,967 | - | - | 81,967 | Dec 15, 2023 |
| Dec 13, 2023 | INAB IN8BIO, INC. | AGrant or award Series A Warrants (right to buy)derivative | +81,967 | - | - | 81,967 | Dec 15, 2023 |
| Dec 13, 2023 | INAB IN8BIO, INC. | AGrant or award Series B Warrants (right to buy)derivative | +81,967 | - | - | 81,967 | Dec 15, 2023 |
| Dec 6, 2023 | INAB IN8BIO, INC. | AGrant or award Stock Option (right to buy)derivative | +54,800 | $0.00 | $0 | 54,800 | Dec 8, 2023 |
Questions about Corinne Epperly
Answered from the filings on this page, as of the latest one.
Is Corinne Epperly buying or selling?
Corinne Epperly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Corinne Epperly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Corinne Epperly has 0.
Where does Corinne Epperly file Form 4?
Corinne Epperly has filed Form 4 at INAB (IN8BIO, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.